Ozempic and Wegovy maker courts prominent Black leaders to get Medicare's favor Drugmaker Novo Nordisk focuses on Black lawmakers and o...
Ozempic and Wegovy maker courts prominent Black leaders to get Medicare's favor
Drugmaker Novo Nordisk focuses on Black lawmakers and opinion leaders to spread the message that obesity is a chronic disease — worth treating at a cost of $1,000 or more a month.
Read more on NPR
Drugmaker Novo Nordisk focuses on Black lawmakers and opinion leaders to spread the message that obesity is a chronic disease — worth treating at a cost of $1,000 or more a month.
Read more on NPR
